Yahoo Finance

Operations: The company generates revenue primarily through its Automated Microscopy Systems and Reagents in the field of Hematology, totaling SEK 708.28 million.

Estimated Discount To Fair Value: 23.2%

CellaVision, priced at SEK 249, appears undervalued with a fair value estimate of SEK 321.68 based on discounted cash flow analysis. The company's earnings are poised for significant growth, forecasted to expand by 24% annually over the next three years, outpacing the Swedish market's 14.2%. Recent financials show robust year-on-year increases in sales and net income for Q1 2024. Additionally, CellaVision maintains a healthy dividend policy with a recent payout of SEK 2.25 per share.

• Insights from our recent growth report point to a promising forecast for CellaVision's business outlook.

• Get an in-depth perspective on CellaVision's balance sheet by reading our health report here.

Sweco

Overview: Sweco AB (publ) offers architecture and engineering consultancy services globally, with a market capitalization of SEK 54.14 billion.

Operations: Sweco's revenue is generated from various regional segments, including SEK 8.52 billion from Sweden, SEK 3.94 billion from Belgium, SEK 3.67 billion from Finland, SEK 3.39 billion from Norway, SEK 2.98 billion from Denmark, SEk 2.89 billion from the Netherlands, and SEK 2.62 billion from Germany & Central Europe.

Estimated Discount To Fair Value: 30.2%

Sweco, trading at SEK 149.4, is valued below its estimated fair value of SEK 216.16, suggesting it's undervalued based on discounted cash flow analysis. Despite a recent dip in net income and earnings per share in Q1 2024, Sweco is poised for steady growth with revenue and earnings forecasted to grow at 5.3% and 16.41% annually, respectively—both rates exceeding the Swedish market averages. However, its dividend track record remains unstable amidst expanding strategic roles in green hydrogen projects across Europe.

• Upon reviewing our latest growth report, Sweco's projected financial performance appears quite optimistic.

• Navigate through the intricacies of Sweco with our comprehensive financial health report here.

Where To Now?

• Click this link to deep-dive into the 44 companies within our Undervalued Swedish Stocks Based On Cash Flows screener.

• Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools.

• Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.

Want To Explore Some Alternatives?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.

• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include OM:ACAD OM:CEVI and OM:SWEC B.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com